default author photo

Robert I. Haddad

Department of Medical Oncology

450 Brookline Avenue

Boston, MA 02115

United States

SCHOLARLY PAPERS

2

DOWNLOADS

152

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Avelumab in Combination with Standard of Care Chemoradiotherapy Versus Chemoradiotherapy Alone in Patients with Locally Advanced SCCHN: A Randomised, Double-Blind, Phase 3 Trial

Number of pages: 28 Posted: 09 Sep 2020
Memorial Sloan Kettering Cancer Center - Department of Radiation Oncology, NHS Foundation Trust - Royal Marsden Hospital, University of Pittsburgh - Hillman Cancer Center, - Section of Medical Oncology, Harvard University - Department of Medical Oncology, National Cancer Center Hospital East, Groupe d'Oncologie Radiothérapie Tête et Cou (GORTEC), National Yang Ming University - Taipei Veterans General Hospital, Changhua Christian Hospital - Department of Radiation Oncology, University of Oklahoma - Stephenson Cancer Center, Instituto Português de Oncologia de Coimbra Francisco Gentil, Semmelweis University - Department of Oncology, Centre Hospitalier Prive Saint Grégoire - CHP Saint Grégoire, Costa del Sol Hospital - Department of Medical Oncology, Fudan University - Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, Budgetary Institution of Healthcare of the Omsk Region - Clinical Oncology Dispensary, Pfizer AG, Pfizer, Inc., Pfizer, Inc. and University of California, San Diego (UCSD) - Moores Cancer Center
Downloads 97

Abstract:

Loading...

avelumab, JAVELIN Head and Neck 100, PD-L1, squamous cell carcinoma of the head and neck, immunotherapy, radiation, chemotherapy

2.

Integrated Clinico-Genomic Analysis of Genetic Ancestry in 1,614 Patients With Cancer Treated With Immune Checkpoint Inhibitors

Number of pages: 57 Posted: 11 Feb 2022
Harvard University - Lank Center for Genitourinary Oncology, Harvard University - Lank Center for Genitourinary Oncology, Harvard University - Brigham and Women's Hospital, Harvard University - Lank Center for Genitourinary Oncology, Harvard University - Division of Population Sciences, Harvard University - Department of Medicine, Harvard University - Lank Center for Genitourinary Oncology, Mount Sinai Health System - Division of Hematology and Medical Oncology, Harvard University - Center for Prevention of Progression of Blood Cancers, Harvard University - Department of Urologic Surgery, Harvard University - Lank Center for Genitourinary Oncology, Harvard University - Lank Center for Genitourinary Oncology, Harvard University - Lank Center for Genitourinary Oncology, Harvard University - Department of Medical Oncology, Harvard University - Department of Radiation Oncology, Harvard University - Department of Medical Oncology, Harvard University - Melanoma Center, Harvard University - Department of Pathology, Harvard University - Department of Data Science, Harvard University - Department of Medicine, Harvard University - Lank Center for Genitourinary Oncology, Harvard University - Division of Genetics and Harvard University - Division of Population Sciences
Downloads 55

Abstract:

Loading...

Genetic ancestry, cancer, Immunotherapy, immune checkpoint inhibitors